HUP9902834A2 - CD44 génkifejezés szabályozása gyógyászati alkalmazásra - Google Patents

CD44 génkifejezés szabályozása gyógyászati alkalmazásra

Info

Publication number
HUP9902834A2
HUP9902834A2 HU9902834A HUP9902834A HUP9902834A2 HU P9902834 A2 HUP9902834 A2 HU P9902834A2 HU 9902834 A HU9902834 A HU 9902834A HU P9902834 A HUP9902834 A HU P9902834A HU P9902834 A2 HUP9902834 A2 HU P9902834A2
Authority
HU
Hungary
Prior art keywords
icn
control
gene expression
therapeutic use
icn248
Prior art date
Application number
HU9902834A
Other languages
English (en)
Inventor
Dariusz Cieslak
Zbigniew Pietrzkowski
Sabera Ruzdijic
Original Assignee
Icn Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals Inc. filed Critical Icn Pharmaceuticals Inc.
Priority to HU9902834A priority Critical patent/HUP9902834A3/hu
Priority claimed from PCT/US1996/012598 external-priority patent/WO1997006827A1/en
Publication of HUP9902834A2 publication Critical patent/HUP9902834A2/hu
Publication of HUP9902834A3 publication Critical patent/HUP9902834A3/hu

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CD-44-et túlzőtt mértékben kifejező ráksejteket, különösen nem-kissejtes tüdőrák- és melanómiasejteket kezelnek antiszensz őligőnűk-leőtidőkkal, hőgy a C44 kifejezését kőrlátőzzák. A vizsgált eredményekazt műtatják, hőgy az őltalmazni kívánt őligőnűkleőtidők jelentősencsökkentik a sejtnövekedést és tüdőrák- és melanómiasejtek esetében,CD44-re fajlagős módőn, űgyanakkőr nem tőxikűsak a nőrmális sej-tekre. ŕ
HU9902834A 1996-07-31 1996-07-31 Control of cd44 gene expression for therapeutic use HUP9902834A3 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU9902834A HUP9902834A3 (en) 1996-07-31 1996-07-31 Control of cd44 gene expression for therapeutic use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902834A HUP9902834A3 (en) 1996-07-31 1996-07-31 Control of cd44 gene expression for therapeutic use
PCT/US1996/012598 WO1997006827A1 (en) 1995-08-14 1996-07-31 Control of cd44 gene expression for therapeutic use

Publications (2)

Publication Number Publication Date
HUP9902834A2 true HUP9902834A2 (hu) 1999-12-28
HUP9902834A3 HUP9902834A3 (en) 2001-04-28

Family

ID=89999088

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902834A HUP9902834A3 (en) 1996-07-31 1996-07-31 Control of cd44 gene expression for therapeutic use

Country Status (1)

Country Link
HU (1) HUP9902834A3 (hu)

Also Published As

Publication number Publication date
HUP9902834A3 (en) 2001-04-28

Similar Documents

Publication Publication Date Title
PL330313A1 (en) Tissue regeneration modulators
EP0629633A3 (en) Dinucleotide analogues, intermediates therefor and oligonucleotides derived therefrom.
IL134042A0 (en) Modified dorsal tissue affecting factor and compositions
EP2028274A3 (en) An antisense oligonucleotide against the TGF-beta2 gene
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
TWI255854B (en) Baculovirus containing minimal CMV promoter
IL157644A0 (en) Method for the purification of a protein preparation with erythropoietin activity
WO2001047944A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU5720498A (en) Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
AU4848793A (en) Oligonucleotide and nucleotide amine analogs, methods of synthesis and use
WO1998059040A3 (de) Humane katalytische telomerase-untereinheit und deren diagnostische und therapeutische verwendung
WO1997027284A3 (en) Human rad50 and septin-2 genes and methods of use
WO2000029623A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP0775745A3 (en) Cathepsin G-inhibiting aptamers
EP1131107A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF INHIBITOR-KAPPA-B-KINASE-ALPHA
NZ331063A (en) Isolated nucleotide sequences encoding for mature LS- DNase which is resistant to actin inhibition
GB2297328B (en) Nucleic acid sequence encoding a human H2 receptor region, and oligonucleotide primers for amplification and sequencing thereof
HUP9902834A2 (hu) CD44 génkifejezés szabályozása gyógyászati alkalmazásra
ZA966661B (en) Catalyst, use thereof and preparation process.
MX220674B (en) Process for hydrolysis of adiponitrile and prodn. of nylon 6,6 utilizing low catalyst levels
AU4512693A (en) Nucleotide sequences coding for a thermostable dna polymerase, dna polymerase and uses thereof
HUP9901346A3 (en) Deltap62, variants thereof, nucleic acid sequences and uses thereof
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
ITTO940379A0 (it) Sequenze specifiche per il dna umano.
AU6358096A (en) New immunoregulatory protein lst-1